SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2024 on Thursday, August 1, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Location: http://investor.resmed.com Date:
Omnicell (OMCL) remains a key player in automating and modernizing global medication management infrastructure.
ResMed, Badger Meter, Leidos and Ingersoll Rand are part of the Zacks Screen of the Week article.